NOMD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Not a good buy right now: price is pressing near resistance (R1 ~$12.92) with an overbought short-term momentum backdrop (RSI-6 ~73.6) and no Intellectia buy signals.", "Near-term edge looks unfavorable: pattern-based forward odds imply mild downside bias over the next week/month (-1.4% / -2.14%).", "Best risk/reward for an impatient buyer is not present at $12.88; the cleaner entry would be on a pullback toward the ~$12.44 pivot (or lower) or after the 2026-02-27 earnings catalyst."]
["Trend/momentum: MACD histogram is positive (0.103) but contracting, suggesting bullish momentum is fading rather than accelerating.", "RSI: RSI-6 at ~73.6 indicates short-term overbought/extended conditions, increasing the odds of a pause or pullback.", "Moving averages: converging MAs point to limited trend strength and a potential consolidation zone rather than a strong breakout trend.", "Key levels: Pivot ~$12.44; Resistance R1 ~$12.92 (price ~$12.88 is very close), R2 ~$13.22; Supports S1 ~$11.97, S2 ~$11.67.", "Market context: S&P 500 down ~1.09% today, which is a mild headwind for risk appetite.", "Intellectia Proprietary Trading Signals\n- AI Stock Picker: No signal on given stock today.\n- SwingMax: No signal on given stock recently."]
["Dividend catalyst: declared $0.17 quarterly dividend (payable 2026-02-26; record date 2026-02-11), supportive for income-focused demand.", "Upcoming event: QDEC 2025 earnings on 2026-02-27 (pre-market) can reset the narrative if results/guide beat expectations.", "Analyst stance remains constructive overall (ratings still Buy/Outperform despite target cuts)."]
while short-term momentum looks extended (RSI-6 >70), raising pullback risk.", "Recent fundamentals have weakened (latest reported quarter shows YoY declines in revenue, income, EPS, and margin), which can cap upside into earnings.", "Analysts have been cutting price targets (valuation compression/competition concerns), which often limits multiple expansion.", "No supportive \u201csmart money\u201d impulse in the provided flow data: hedge funds and insiders are both described as neutral; no recent Congress trading data to indicate influential buying."]
["Latest quarter provided: 2025/Q3.", "Revenue: $752.4M, down ~2.23% YoY (top-line contraction).", "Net income: $57.6M, down ~18.07% YoY (profit decline faster than revenue).", "EPS: $0.39, down ~11.36% YoY.", "Gross margin: ~27.57%, down ~14.51% YoY (margin compression is the key negative growth signal)."]
["Recent changes are negative on targets but positive on ratings: targets were lowered while maintaining Buy/Outperform.", "2026-01-08: Mizuho cut PT to $15 from $17; kept Outperform; cited competition/valuation compression and macro uncertainty limiting broad re-rating.", "2025-11-07: Deutsche Bank cut PT to $16 from $18; kept Buy.", "Wall Street pros: still sees upside versus $12.88 (targets $15\u2013$16), and the business is viewed as a steady food producer with shareholder returns (dividend).", "Wall Street cons: target cuts highlight concern about competitive pressure, softer fundamentals, and limited near-term valuation recovery."]
